How is this wintersweet oil positioned under FDA rules for the US market?
For US cosmetics the oil is a cosmetic ingredient under FD&C/MoCRA with INCI labeling (CHIMONANTHUS PRAECOX FLOWER OIL); aromatherapy products must make no drug claims. For food-flavoring use, its status must be confirmed against FDA 21 CFR flavoring provisions and FEMA GRAS verification.
US Market Positioning
| Use | Regulatory basis |
|---|---|
| Cosmetics | FD&C / MoCRA cosmetic ingredient, INCI labeling |
| Aromatherapy | No drug claims permitted |
| Food flavoring | FDA 21 CFR + FEMA GRAS verification |
- English composition data and SDS are provided for your dossier
- CIR assessment data on wintersweet flower oil supports cosmetics safety review
- Finished-product labeling must follow US requirements, including allergen notes
We can prepare English technical files for your US importer or formulator.
Relate Products
This article was published on 2026-09-07, and last updated on 2026-09-07. The article will be continuously updated.
